0000950170-24-073234.txt : 20240613
0000950170-24-073234.hdr.sgml : 20240613
20240613191415
ACCESSION NUMBER: 0000950170-24-073234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferrante Karen Jean
CENTRAL INDEX KEY: 0001598502
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 241042651
MAIL ADDRESS:
STREET 1: 150 ADIRONDACK DRIVE
CITY: EAST GREENWICH
STATE: RI
ZIP: 02818
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cogent Biosciences, Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 WYMAN STREET
STREET 2: 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 275 WYMAN STREET
STREET 2: 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics Inc.
DATE OF NAME CHANGE: 20180402
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
ownership.xml
4
X0508
4
2024-06-05
0001622229
Cogent Biosciences, Inc.
COGT
0001598502
Ferrante Karen Jean
C/O COGENT BIOSCIENCES, INC.
275 WYMAN STREET, 3RD FLOOR
WALTHAM
MA
02451
true
false
false
false
false
Stock Option (Right to Buy)
8.92
2024-06-05
4
A
false
44700
0.00
A
2034-06-05
Common Stock
44700
44700
D
This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders.
/s/ Evan D. Kearns, Attorney-in-Fact
2024-06-13